Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Rheumatoid ArthritisHealthy Subjects
Interventions
DRUG

warfarin

2 single 25 mg doses of Warfarin (5 x 5 mg tablets) administered 14 days apart

DRUG

fostamatinib

2 x 50 mg Fostamatinib tablets (100 mg) twice daily for 13 days

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY